Actos 15 mg tablets
Sponsors
Karolinska University Hospital, Centre Hospitalier De Versailles
Conditions
CHRONIC PHASE CHRONIC MYELOGENOUS LEUKAEMIA (CP-CML)Diabetes type 2
Phase 2
Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes: A Randomized Open Intervention Study That Compares Empagliflozin, Pioglitazone and Semaglutide (DiaSpax)
RecruitingCTIS2024-513416-98-00
Start: 2023-01-23Target: 90Updated: 2025-11-25
CANDIDATE THERAPIES IN COMBINATION OR SEQUENTIALLY WITH TYROSINE KINASE INHIBITORS IN CHRONIC PHASE CHRONIC MYELOGENOUS LEUKAEMIA (CP-CML) PATIENTS IN COMPLETE CYTOGENETIC RESPONSE WITHOUT ACHIEVING A DEEP MOLECULAR RESPONSE: AN ADAPTIVE TRIAL BASED ON A DROP LOSER DESIGN - ACTIW STUDY
Not yet recruitingCTIS2024-516328-32-00
Target: 250Updated: 2024-09-16